FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.27), $0.08 better than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.
... More
